Alnylam Pharmaceuticals
ALNY
ALNY
215 hedge funds and large institutions have $5.62B invested in Alnylam Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 55 increasing their positions, 86 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
11% more funds holding in top 10
Funds holding in top 10: 9 → 10 (+1)
36% less repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 86
Holders
215
Holding in Top 10
10
Calls
$36.6M
Puts
$20.5M
Top Buyers
| 1 | +$133M | |
| 2 | +$83.2M | |
| 3 | +$49.8M | |
| 4 |
BRC
Blue Ridge Capital
New York
|
+$41.7M |
| 5 |
D.E. Shaw & Co
New York
|
+$17.2M |
Top Sellers
| 1 | -$188M | |
| 2 | -$49.5M | |
| 3 | -$41.6M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$39.5M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$24.9M |